BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19273133)

  • 21. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
    Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
    J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
    Fleischer S; Wiemann S; Will H; Hofmann TG
    Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PML nuclear bodies.
    Lallemand-Breitenbach V; de Thé H
    Cold Spring Harb Perspect Biol; 2010 May; 2(5):a000661. PubMed ID: 20452955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanisms of PML-nuclear body formation.
    Shen TH; Lin HK; Scaglioni PP; Yung TM; Pandolfi PP
    Mol Cell; 2006 Nov; 24(3):331-9. PubMed ID: 17081985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.
    Gao C; Ho CC; Reineke E; Lam M; Cheng X; Stanya KJ; Liu Y; Chakraborty S; Shih HM; Kao HY
    Mol Cell Biol; 2008 Sep; 28(18):5658-67. PubMed ID: 18625722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
    Komatsu T; Nagata K; Wodrich H
    J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK
    Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Implication of PML nuclear bodies in intrinsic and innate immunity].
    Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
    Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.
    Chung YL; Tsai TY
    Mol Cancer Res; 2009 Oct; 7(10):1672-85. PubMed ID: 19808906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PML modulates epigenetic composition of chromatin to regulate expression of pro-metastatic genes in triple-negative breast cancer.
    Fracassi C; Ugge' M; Abdelhalim M; Zapparoli E; Simoni M; Magliulo D; Mazza D; Lazarevic D; Morelli MJ; Collas P; Bernardi R
    Nucleic Acids Res; 2023 Nov; 51(20):11024-11039. PubMed ID: 37823593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PML nuclear bodies and their spatial relationships in the mammalian cell nucleus.
    Batty E; Jensen K; Freemont P
    Front Biosci (Landmark Ed); 2009 Jan; 14(3):1182-96. PubMed ID: 19273124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient mutations alter ATRX targeting to PML nuclear bodies.
    Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
    Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism.
    Eskiw CH; Dellaire G; Bazett-Jones DP
    J Biol Chem; 2004 Mar; 279(10):9577-85. PubMed ID: 14672938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death.
    Guan D; Lim JH; Peng L; Liu Y; Lam M; Seto E; Kao HY
    Cell Death Dis; 2014 Jul; 5(7):e1340. PubMed ID: 25032863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
    Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
    Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.